Optimizing autophagy modulation for enhanced TRAIL‐mediated therapy: Unveiling the superiority of late‐stage inhibition over early‐stage inhibition to overcome therapy resistance in cancer.

Zinnah, Kazi Mohammad Ali; Munna, Ali Newaz; Park, Sang‐Youel

Autophagy is a vital mechanism that eliminates large cytoplasmic components via lysosomal degradation to maintain cellular homeostasis. The role of autophagy in cancer treatment has been studied extensively. Autophagy primarily prevents tumour initiation by maintaining genomic stability and preventing cellular inflammation. However, autophagy also supports cancer cell survival and growth by providing essential nutrients for therapeutic resistance. Thus, autophagy has emerged as a promising strategy for overcoming resistance and enhancing anti‐cancer therapy. Inhibiting autophagy significantly improves the sensitivity of lung, colorectal, breast, liver and prostate cancer cells to tumour necrosis factor‐related apoptosis‐inducing ligand (TRAIL). This review investigates the intricate interplay between autophagy modulation and TRAIL‐based therapy, specifically focussing on comparing the efficacy of late‐stage autophagy inhibition versus early‐stage inhibition in overcoming cancer resistance. We expose the distinctive advantages of late‐stage autophagy inhibition by exploring the mechanisms underlying autophagy's impact on TRAIL sensitivity. Current preclinical and clinical investigations are inspected, showing the potential of targeting late‐stage autophagy for sensitizing resistant cancer cells to TRAIL‐induced apoptosis. This review emphasizes the significance of optimizing autophagy modulation to enhance TRAIL‐mediated therapy and overcome the challenge of treatment resistance in cancer. We offer insights and recommendations for guiding the development of potential therapeutic strategies aimed at overcoming the challenges posed by treatment‐resistant cancers.

CANCER cell growth; ESSENTIAL nutrients; AUTOPHAGY; LIVER cancer; CANCER cells; BREAST; LUNGS

Basic & Clinical Pharmacology & Toxicology, 2025, Vol 136, Issue 1, p1

1742-7835

Academic Journal

10.1111/bcpt.14110